Experimental model of inappropriate sinus tachycardia: Initiation and ablation

被引:16
|
作者
Scherlag, BJ [1 ]
Yamanashi, WS [1 ]
Amin, R [1 ]
Lazzara, R [1 ]
Jackman, WM [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Cardiac Arrhythmia Res Inst, Oklahoma City, OK USA
关键词
sinus tachycardia; autonomic nervous system; heart rate; blood pressure; adrenergic agonists;
D O I
10.1007/s10840-005-1045-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The purpose of the present study was to develop an experimental model of inappropriate sinus tachycardia (IST) by injecting a catecholamine into a fat pad containing autonomic ganglia (AG) innervating the sinus node (SN). Methods: Initial protocols in 3 groups of pentobarbital anesthetized dogs consisted of ( 1) slowing the heart rate (HR) by electrical stimulation of AG in the fat pad; ( 2) the effect of intravenous injection of epinephrine ( 0.1 - 0.3 mg) on the HR and systolic blood pressure ( BP); ( 3) the response of SN rate to intravenously injected isoproterenol ( 1 mu gm/kg). These studies established a reference for the response to epinephrine injection ( mean dose 0.2 +/- 0.9 mg, n= 14) into the fat pad at the base of the right superior pulmonary vein (RSPV). ECG leads, right atrial and His bundle electrograms, BP and core body temperature were continuously monitored. Results: Epinephrine, injected into the fat pad, caused a significant increase in heart rate ( HR, average: 211 +/- 11/ min, p< 0.05 compared to control) but little change in systolic BP, 149 +/- 10 mmHg, p= NS ( Group I, N= 8). The tachycardia lasted >= 30 minutes. Ice mapping and P wave morphology showed the tachycardia origin in the SN in 6/8 and in the crista terminalis (CT) in 2. Injection of 0.4 cc of formaldehyde into the FP restored HR ( 159 +/- 16) toward baseline ( 154 +/- 18). In Group II ( N= 6), the same regimen induced a significant increase in both HR and systolic BP ( 194 +/- 17/ min and 230 +/- 24 mmHg, respectively) compared to control values ( 143 +/- 23/ min, 162 +/- 24 mmHg) which lasted for > 30 minutes. Ice mapping and P wave morphology showed that the pacemaker was in the SN ( 1), overlying the CT ( 2), or atrioventricular junction ( 2). Formaldehyde ( 0.4 cc) injected into the FP restored both HR and systolic BP toward baseline values ( 148 +/- 29/ min and 152 +/- 24 mmHg, p= NS) and prevented, slowing of the HR by electrical stimulation of the AG; moreover, the same dose of epinephrine injected intravenously increased HR and SBP but only for 2 - 5 minutes; Isoproterenol ( 1 mu g/kg) injected intravenously induced essentially the same increase in sinus rate after AG ablation as in the control state ( 194 +/- 15/ min vs 193 +/- 23/ min, p= NS). Conclusion: Experimental IST is mainly localized in the SN or CT. Ablation of the AG terminates IST without impairing the SN response to an adrenergic challenge.
引用
收藏
页码:21 / 29
页数:9
相关论文
共 50 条
  • [41] Nonreentrant Supraventricular Tachycardia Misdiagnosed as Inappropriate Sinus Tachycardia
    Bhatt, Advay G.
    Monahan, Kevin M.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2011, 34 (08): : E70 - E73
  • [42] Inappropriate sinus tachycardia: Evaluation and therapy
    Krahn, AD
    Yee, R
    Klein, GJ
    Morillo, C
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1995, 6 (12) : 1124 - 1128
  • [43] Ivabradine in patients with inappropriate sinus tachycardia
    Zellerhoff, S.
    Hinterseer, M.
    Krull, B. F.
    Schulze-Bahr, E.
    Breithardt, G.
    Kirchhof, P.
    Kaab, S.
    EUROPEAN HEART JOURNAL, 2008, 29 : 40 - 40
  • [44] Ivabradine in patients with inappropriate sinus tachycardia
    Zellerhoff, Stephan
    Hinterseer, Martin
    Krull, Bastian Felix
    Schulze-Bahr, Eric
    Fabritz, Larissa
    Breithardt, Guenter
    Kirchhof, Paulus
    Kaeaeb, Stefan
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2010, 382 (5-6) : 483 - 486
  • [45] Epidemiology and definition of inappropriate sinus tachycardia
    Pellegrini, Cara N.
    Scheinman, Melvin M.
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2016, 46 (01) : 29 - 32
  • [46] The use of ivabradine for inappropriate sinus tachycardia
    Weyn, Tim
    Stockman, Dirk
    Degreef, Yves
    ACTA CARDIOLOGICA, 2011, 66 (02) : 259 - 262
  • [47] Challenges in Treatment of Inappropriate Sinus Tachycardia
    Ruzieh, Mohammed
    Moustafa, Abdelmoniem
    Sabbagh, Ebrahim
    Karim, Mohammad M.
    Karim, Saima
    CURRENT CARDIOLOGY REVIEWS, 2018, 14 (01) : 42 - 44
  • [48] Ivabradine as treatment of inappropriate sinus tachycardia
    Romero-Rodriguez, Nieves
    Baron-Esquivias, Gonzalo
    Gonzalez Vargas-Machuca, Manuel
    Martinez Martinez, Angel
    MEDICINA CLINICA, 2010, 135 (09): : 428 - 429
  • [49] Inappropriate sinus tachycardia - ailment or disease?
    Ptaszynski, Pawel
    Kaczmarek, Krzysztof
    Poddebska, Izabela
    Cygankiewicz, Iwona
    KARDIOLOGIA POLSKA, 2013, 71 (10) : 1087 - 1089
  • [50] Conventional management of inappropriate sinus tachycardia
    Olshansky, Brian
    Sullivan, Renee M.
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2016, 46 (01) : 43 - 45